International journal of dermatology
Risk of Dyslipidemia Associated With Oral Janus Kinase Inhibitors: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
Daniel Isufi, Niloufar Javanmardi, Mikkel Bak Jensen, Nikolai Loft, Lone Skov, Jesper Elberling, Simon Francis Thomsen, Farzad Alinaghi
Published: 202510.1111/ijd.70122
Abstract
Janus kinase inhibitors (JAKi) have sparked a new era in the treatment of immune-mediated diseases. While some studies have reported an increased incidence of dyslipidemia in JAKi-treated patients, the full extent of this adverse event is not establi…
Preview only. Read the full abstract at the source